ABAdrienn Biró

Adrienn Biró

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adrienn Biró has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Zsolt Káposztás

    Department of Surgery, Moritz Kaposi General Hospital, Kaposvár, Hungary

    5 shared publications
  • László Ternyik

    Department of Surgery, Moritz Kaposi General Hospital, Kaposvár, Hungary

    4 shared publications
  • István Bálint

    Somogy Megyei Kaposi Mór Oktató Kórház, Sebészeti Osztály, Kaposvár, Tallián Gy. u. 20–32., 7400

    3 shared publications
  • Zsolt Káposztás

    Department of Surgery, Somogy County Kaposi Mor Teaching Hospital, Kaposvár, Hungary

    3 shared publications
  • Dezső Tóth

    Institute of Surgery, University of Debrecen, Debrecen, Hungary

    2 shared publications
  • Veronika Czoma

    Department of Pathology, Moritz Kaposi General Hospital, Kaposvár, 20-32. Tallián Gy. Street, Kaposvár 7400, Hungary

    2 shared publications

Latest Publications

  • Open Access

    Clinical and economic impact of a multidisciplinary antimicrobial stewardship program in a septic surgery unit

    by Adrienn Biró, Lilla Sáfár, Sára Merczel, Zsolt Káposztás

    Objective: This study evaluated the clinical, epidemiological, and economic outcomes associated with the implementation of a multidisciplinary antimicrobial stewardship program (ASP) at the 24-bed Septic Surgery Unit of the Somogy County Kaposi Mór Teaching Hospital. The primary objective was to assess changes in direct antimicrobial procurement expenditures, consumption metrics, and healthcare-associated pathogen patterns, while monitoring 30-day all-cause mortality as a core safety endpoint. Methods: In this quantitative retrospective before-after cohort study following the ORION and SQUIRE 2.0 guidelines, data from two one-year periods were evaluated: pre-intervention (1 October 2022 to 30 September 2023) and post-intervention (1 October 2023 to 30 September 2024). Evaluated metrics included Defined Daily Dose (DDD) per 1,000 patient-days, Days of Therapy (DOT) per 1,000 patient-days, mean overall duration of antibiotic (AB) therapy per treated patient, gross institutional procurement costs, length of stay (LOS), and 30-day all-cause mortality from admission. Group comparisons were analyzed using the Independent Samples t-test for continuous variables, and the Chi-square (χ²) test or Fisher’s exact test for categorical variables. Results: Following ASP implementation, cumulative DDD increased by 23.00% (from 4,037.44 to 4,965.85 DDD, p = 0.003, 673.52 to 832.36 DDD/1,000 patient-days), while the total drug procurement cost decreased by 25.09% (from 6,451,451 HUF to 4,832,680 HUF, p = 0.006). Active AB exposure altered from 626.88 to 691.26 DOT per 1,000 patient-days. The mean duration of therapy per treated patient decreased from 5.68 (SD +/- 3.22) to 5.30 (SD +/- 3.23) days ( p = 0.028), and de-escalation practices improved, with reduced intravenous (IV) (80.00% to 71.15%) and increased oral treatment (PO) (20.00% to 28.85%, p < 0.001). The incidence density (ID) of glycopeptide-resistant Gram-positive cocci decreased by 87.07% ( p = 0.039), and methicillin-resistant staphylococci decreased by 74.13% ( p = 0.034), observed in conjunction with reinforced barrier infection control measures. All-cause 30-day mortality was 10.03% pre-intervention and 9.00% post-intervention ( p = 0.545), confirming non-inferior clinical safety. Conclusions: Implementation of a multidisciplinary ASP in a septic surgery environment was associated with substantial direct cost savings, accelerated IV-to-PO conversion, and a reduced mean duration of patient therapy without compromising clinical safety, despite an administrative expansion in cumulative DDD metrics.

  • Open Access

    Two Decades of Living with Echinococcus multilocularis: A Clinical Epidemiology Study on Human Alveolar Echinococcosis in Hungary

    by Eszter Csulak, Damján Pekli, Ágnes Csivincsik, Sibusiso Moloi, Balázs Dezsényi, József Danka, Krisztina Hagymási, Oszkár Hahn, Judit Halász, Norbert Völcsei, et al.

    Introduction The zoonotic parasite Echinococcus multilocularis emerged in Hungary in the early 2000s. During the next two decades, it continuously spread in both wildlife and the human population. The first comprehensive epidemiological study on human alveolar echinococcosis (HAE) was carried out in 2018. Then, a remarkable increase in HAE cases was detected in Hungary. Methods Our study aimed to identify the potential causes of trend alterations in the epidemiology of HAE. Thus, we compared the terms before (2003–2018) and after (2019–2024) the comprehensive analysis, focusing on disease outcomes and their associated background factors. Results We found that, during the latter study period, the prognosis of HAE improved (proportion of improving cases increased from 23.5% to 60.9%, p = 0.0006) owing to the shortening of diagnostic delay (47.1% versus 78.3% of delay within 12 months, p = 0.029), development in surgery (17.6% versus 26.1% of surgeries were R1/R2, p = 0.57) and medication (35.3% versus 73.9% of medications proved adequate, p = 0.015); however, the proportion of advanced-stage cases entering the healthcare system remained high (56.25% versus 56.52%). On the other hand, a non-significant increase in case numbers was experienced in the southwestern part of the country (11.77% versus 26.09% of all cases in Hungary). Conclusion We conclude that public interest arose from the first comprehensive HAE study that increased disease awareness within the healthcare system and contributed to better diagnoses and more efficient therapy. However, public awareness needs improvement, since the proportion of advanced-stage HAE did not decrease between the two study periods. Besides, the southwestern hotspot needs more attention and intervention.


  • Reply to Letter to Editor

    by Adrienn Biró, Zsolt Káposztás


  • Open Access

    Comparison of Resected Malignant Tumors of the Right- and Left-Sided Colon—Is There a Difference?

    by Adrienn Biró, László Ternyik, Krisztián Somodi, Anna Dawson, Eszter Csulak, Dezső Tóth, Mariann Moizs, Zsolt Káposztás

    Embryological, anatomical, and immunological differences between the right-sided and left-sided colons are well known, but the difference in oncological behavior of colon tumors has only recently become the main subject of studies. Published articles propose that there is a difference not only in symptoms, but also in survival. Our aim was to analyze the clinicopathological and oncological differences among our patients who had been operated for colon cancer in our department. We examined the historical data of our patients who underwent colon resection for malignancy between 1st of January 2016 and 31st of December 2018. Tumor markers, histological results, postoperative complications, and oncological therapies were investigated. The primary outcome was overall survival. We analyzed our patients’ survival data with Kaplan–Meier log-rank test and Cox regression analysis. In our study, 267 patients were enrolled. One hundred thirty-three (49.8%) patients had right-sided colon cancer; 134 (50.2%) patients had left-sided colon cancer. Patients with right-sided colon cancer were significantly more likely to have mucinous adenocarcinoma (p = 0.037). No significant differences were revealed in overall survival between right-sided colon cancer and left-sided colon cancer patients (p = 0.381). Additional subgroup analysis showed that there were no significant differences in overall survival for laterality neither in the metastatic group (p = 0.824) nor in the non-metastatic group (p = 0.345). Based on the conflicting previous study results, our findings repeatedly highlight that the relationship between tumor location in the colon and overall survival is not straightforward.


  • Open Access

    Significance of preoperative blood tests in the prognosis of colorectal cancer: A prospective, multicenter study from Hungary

    by Adrienn Biró, Péter Kolozsi, Attila Nagy, Zsolt Varga, Zsolt Káposztás, Dezső Tóth

    Background: The focus of this study was to analyze the prognostic value of different combinations of inflammatory and coagulation factors using preoperative blood and to appraise the clinical importance of these biomarkers in colorectal cancer patients.Methods: A prospective, multicenter study included patients undergoing radical colorectal surgery in three county hospitals. Inflammatory and coagulation markers were analyzed preoperatively.Results: Two hundred and one patients were included. We examined patients based on their tumor localization. Colon cancer group involved patients with the tumor localized in the colon (n = 105, 52.24%) and rectal cancer group the patients with the tumor in the rectum (n = 96, 47.76%). Examining coagulation factors, univariate Cox analysis of colon cancer patients showed that activated partial thromboplastin time (p = 0.020) was significantly associated with overall survival, but we could not prove it in multivariate analysis. In colon cancer patients, neutrophil‐to‐lymphocyte ratio (NLR, p < 0.001) was positively correlated with tumor size and had significant association (χ2 = 5.48, p = 0.019, df = 1) with perineural invasion. Univariate and multivariate Cox analysis of colon cancer patients showed that NLR (p = 0.011 and p = 0.048) was significantly associated with disease‐free survival (DFS).Conclusion: NLR was proved to be an independent prognostic factor for DFS in patients with non‐metastatic colon cancer. NLR might help to recognize the high‐risk patients between patients with the same tumor‐node‐metastasis stage and could help with the decision on adjuvant chemotherapy. Since the biomarkers in preoperative blood tests are habitually evaluated, NLR could be an inexpensive prognostic marker that can be easily assessed in clinical practice.


  • Open Access

    Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?

    by Istvan Bence Balint, Ferenc Csaszar, Krisztian Somodi, Laszlo Ternyik, Adrienn Biro, Zsolt Kaposztas

    Purpose: Based on recent scientific evidence, bariatric surgery is more effective in the management of morbid obesity and related comorbidities than conservative therapy. Pylorus preserving surgical procedures (PPBS) such as laparoscopic single-anastomosis duodeno-jejunal or duodeno-ileal bypass with sleeve gastrectomy are modified duodenal switch (DS) surgical techniques. The duodeno-jejunal bypass liner (DJBL) is a novel surgical method in the inventory of metabolism focused manual interventions that excludes duodeno-jejunal mucosa from digestion, mimicking DS procedures without the risk of surgical intervention. The aim of this article is to summarize and compare differences between safety-related features and weight loss outcomes of DJBL and PPBS. Methods: A literature search was conducted in the PubMed database. Records of DJBL-related adverse events (AEs), occurrence of PPBS-related complications and reintervention rates were collected. Mean weight, mean body mass index (BMI), percent of excess of weight loss (EWL%), percent of total weight loss (TWL%) and BMI value alterations were recorded for weight loss outcomes. Results: A total of 11 publications on DJBL and 6 publications on PPBS were included, involving 800 and 1462 patients, respectively. The baseline characteristics of the patients were matched. Comparison of DJBL-related AEs and PPBS-related severe complications showed an almost equal risk (risk difference (RD): −0.03 and confidence interval (CI): −0.27 to 0.21), despite higher rates among patients having received endoscopic treatment. Overall AE and complication rates classified by Clavien-Dindo showed that PPBS was superior to DJBL due to an excess risk level of 25% (RD: 0.25, CI: 0.01–0.49). Reintervention rates were more favourable in the PPBS group, without significant differences in risk (RD: −0.03, CI: −0.27 to 0.20). However, PPBS seemed more efficient regarding weight loss outcomes at 1-year follow-up according to raw data, while meta-analysis did not reveal any significant difference (odds ratio (OR): 1.08, CI: 0.74–1.59 for BMI changes). Conclusion: Only limited conclusions can be made based on our findings. PPBS was superior to DJBL with regard to safety outcomes (GRADE IIB), which failed to support the authors’ hypothesis. Surgical procedures showed lower complication rates than the incidence of DJBL-related AEs, although it should be emphasized that the low number of PPBS-related mild to moderate complications reported could be the result of incomplete data recording from the analysed publications. Weight loss outcomes favoured bariatric surgery (GRADE IIB). As the DJBL is implanted into the upper gastrointestinal tract for 6 to 12 months, it seems a promising additional method in the inventory of metabolic interventions.


  • Mesenterialis actinomycosis

    by Adrienn Biró, László Ternyik, Katalin Heckel, István Bálint, Zsolt Káposztás

    Összefoglaló. Egy 46 éves nőbeteg esetét ismertetjük, akinél láz és görcsös hasi fájdalom miatt kezdődött kivizsgálás. A hasi ultrahangvizsgálat során a colon transversum területén megvastagodott falú konglomerátum volt látható. A kolonoszkópia során organikus eltérés nem igazolódott. A hasi komputertomográfiás vizsgálat retroperitonealis térfoglalást írt le, ezért onkológiai bizottság javaslata alapján műtét mellett döntöttünk. Egy hónappal a panaszok jelentkezése után megtörtént a műtét, melynek során úgy tűnt, hogy egy megközelítőleg 5 × 8 centiméteres, a vékonybélből kiinduló, a colon ascendenst és a sigmabelet is érintő, daganatnak imponáló terimét találtunk. Jobb oldali hemicolectomiát végeztünk, és reszekáltuk a sigmabélfal részletét. A szövettani vizsgálat malignitást nem igazolt, hanem a bélfallal összefüggést nem mutató, mesenterialis actinomycosist írt le. A hasi, mesenterialis actinomycosis ritka kórkép, mégis fontos, hogy gondoljunk rá mint differenciáldiagnosztikai lehetőségre, így a beteg a lehető leghamarabb megkaphatja a megfelelő kezelést. Esettanulmányunk bemutatásával a kórkép ismeretének fontosságára szeretnénk felhívni a figyelmet. Orv Hetil. 2021; 162(3): 116–119. Summary. We present the case of a 46-year-old female, who presented with fever and abdominal pain. Abdominal ultrasound revealed a thickened-walled conglomerate near the transvers colon. Colonoscopy did not show any organic abnormality. Abdominal computed tomography described a retroperitoneal mass, so we decided on surgery based on the multidisciplinary team decision. One month after the onset of symptoms, laparotomy was performed, and it seemed that we found an approximately 5 × 8 centimetre tumour attached to the small intestine involving the ascending and sigmoid colon. We performed right hemicolectomy and sigmoid colon wall resection. Histology result showed mesenteric actinomycosis with no connection to the intestinal wall, no malignancy was revealed. Although the abdominal, mesenteric actinomycosis is a rare disease, it is important to think of it as a differential diagnostic option, so the patient can get proper treatment and cured sooner. Our aim with presenting this case report is to highlight the significance of this disease. Orv Hetil. 2021; 162(3): 116–119.


  • Epithelioid hemangioma of liver—The first reported case

    by Adrienn Biro, László Ternyik, Veronika Czoma, Géza Hegedűs, István Bálint, Dezső Tóth, Zsolt Káposztás

    Epithelioid hemangioma, otherwise known as angiolymphoid hyperplasia with eosinophilia, is a rare benign vasoproliferative disease with an unknown etiology. We report the case of a 42-year-old man with routine bloods test showing mildly elevated serum bilirubin level. CT scan revealed a lesion in the left liver lobe not typical of FNH. PET/CT scan and a dynamic liver MRI were consistent with a malignant mass. Surgical resection was performed. Histopathology of the 45 mm mass reported well-defined, slightly lobular proliferations of capillary-sized vessels around several central muscular vessels. Although the endothelial cells revealed a “hobnail” appearance, none of them showed pleomorphism or mitotic activity. Endothelial cells showed reactivity for the endothelial markers (CD34, CD31) and smooth muscle was detected in the blood vessel walls via immunohistochemistry. Despite its benign nature, epithelioid hemangioma of the liver can lead to a diagnostic and therapeutic dilemma due to the malignant looking features on imaging modalities.


  • Appendicitis képében jelentkező akut promyelocytás leukaemia kiújulása allogén csontvelő-transzplantációt követően

    by Adrienn Biró, László Ternyik, Miklós Egyed, István Bálint, Veronika Czoma, Béla Kajtár, Zsolt Káposztás

    Összefoglaló. Az akut myeloid leukaemia ellátása primeren hematológiai feladat, relapsusa során is ritka a sebészeti szövődmény. Esettanulmányunkban egy 46 éves férfi beteget mutatunk be, akinél rutinvérvétel során felfedezett akut promyelocytás leukaemia miatt történt hematológiai kezelés. Alapbetegsége komplett molekuláris remisszióba jutott, ezt követően fenntartó kezeléseket kapott, de betegsége kiújult. Reindukciós kezelést követően fehérvérsejtszáma normalizálódott, de nem jutott molekuláris remisszióba. További kezelés után a férfi testvérétől gyűjtött őssejttel allogén csontvelő-transzplantáció történt. Közel egy éve molekuláris remisszióban volt a beteg, amikor jelentkeztek jobb alhasi panaszai neutropenia, a C-reaktív protein magas értéke és pozitív hasi ultrahang mellett. Akutan laparoszkópos módszerrel távolítottuk el a láthatóan gyulladt féregnyúlványt. A hisztológiai feldolgozás során az akut promyelocytás leukaemia manifesztációja igazolódott. Tekintettel arra, hogy közben csontvelői relapsus is kialakult, újabb reindukciós kezelés, és másik testvérétől vett őssejtekkel ismételten allogén csontvelő-transzplantáció történt. Az általunk ismert irodalomban appendicitis képében jelentkező akut promyelocytás leukaemia relapsusáról nem találtunk közleményt, ezért tartottuk esetünket publikációra érdemesnek. Orv Hetil. 2020; 161(51): 2171–2174. Summary. The treatment of acute myeloid leukemia is primarily hematological. Surgical complications are rare even during relapse. We present the case of a 46-year-old man who was diagnosed with acute promyelocytic leukemia after a routine blood test. Following hematological treatment, molecular remission was achieved, and he was on maintenance therapy, when his leukemia relapsed. He received re-induction treatment and his white blood cell count normalised, however, molecular remission was not reached. After further treatment, allogeneic bone marrow transplantation was performed with stem cells collected from his brother. He developed right lower quadrant abdominal pain with neutropenia, elevated C-reactive protein and abdominal ultrasound report showed thickened appendix after nearly one year of molecular remission. We performed en emergency laparoscopic appendicectomy to remove the inflamed appendix. Histology confirmed acute promyelocytic leukemia manifestation in the appendix. Given the repeated bone marrow relapse, he received re-induction treatment and allogeneic bone marrow transplantation again with stem cells collected from his another brother. To the best of our knowledge, no previous report in the literature can be found of appendicitis mimicking relapse of acute promyelocytic leukemia, thus, this case report holds merit for publication. Orv Hetil. 2020; 161(51): 2171–2174.